c-Myc tag Peptide (A6003): Mechanism, Evidence, and Limits

Executive Summary: The c-Myc tag Peptide (A6003) is a synthetic peptide mimicking the C-terminal 410–419 sequence of human c-Myc. It is used to displace c-Myc-tagged fusion proteins from anti-c-Myc antibodies, enabling specificity controls in immunoassays (APExBIO). Its high purity (>99%) and solubility (≥60.17 mg/mL in DMSO) support reproducible results. The peptide is critical for studying transcription factor regulation, notably c-Myc’s role in cell proliferation, apoptosis, and oncogenesis (Wu et al., 2021). This article clarifies the mechanism, benchmarks, and practical boundaries for researchers.

Biological Rationale

The c-Myc protein is a transcription factor that regulates genes involved in cell cycle progression, growth, apoptosis, and differentiation (Wu et al., 2021). Aberrant c-Myc activation is implicated in tumorigenesis. Experimental tools that precisely modulate or detect c-Myc, such as the c-Myc tag Peptide, are essential in dissecting these pathways (Flagpeptide.com: Precision Tool for Immunoassay). This peptide enables the specific displacement of c-Myc-tagged fusion proteins bound to anti-c-Myc antibodies, facilitating accurate assay controls and validation of c-Myc’s functional roles.

Mechanism of Action of c-Myc tag Peptide

The c-Myc tag Peptide corresponds to amino acids 410–419 of the human c-Myc protein. Its sequence is EQKLISEEDL, which constitutes a commonly used myc tag in molecular biology (APExBIO). When added to immunoassays, the peptide competes with c-Myc-tagged fusion proteins for binding to anti-c-Myc antibodies. This competitive inhibition allows researchers to confirm specificity and to elute or displace tagged proteins from antibody complexes in pull-down or immunoprecipitation workflows (Flag-peptide.com: Advanced Mechanisms). The c-Myc tag Peptide is highly soluble in DMSO (≥60.17 mg/mL) and in water (≥15.7 mg/mL with ultrasonic treatment), but is insoluble in ethanol. Its molecular weight is 1203.3 Da and typical purity exceeds 99% (APExBIO).

Evidence & Benchmarks

• The c-Myc tag Peptide effectively displaces c-Myc-tagged fusion proteins from anti-c-Myc antibodies, enabling competitive inhibition in immunoassays (APExBIO).
• Solubility is ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water (ultrasonicated); insoluble in ethanol (APExBIO).
• The peptide’s purity is typically above 99%, supporting reproducibility and minimizing off-target effects (APExBIO).
• c-Myc is a key transcription factor regulating cell proliferation, apoptosis, and differentiation by activating or repressing cyclins, ribosomal RNA/proteins, and apoptosis regulators such as p21 and Bcl-2 (Wu et al., 2021).
• Specificity of anti-c-Myc antibody binding inhibition by the peptide has been validated in standard immunoprecipitation and Western blot assays (Flagpeptide.com).

This article extends the benchmarks reported in Flagpeptide.com by detailing solubility thresholds and stability parameters, which are critical for experimental planning.

Applications, Limits & Misconceptions

The c-Myc tag Peptide is primarily used for the displacement of c-Myc-tagged fusion proteins in immunoassays, including Western blot, immunoprecipitation, and ELISA. Its use enhances the specificity of detection and quantification by distinguishing true c-Myc interactions from non-specific antibody binding (Flag-peptide.com). Furthermore, it serves as a control to validate the function of anti-c-Myc antibodies and to optimize elution conditions in affinity purification workflows.

Common Pitfalls or Misconceptions

• The c-Myc tag Peptide does not inhibit endogenous c-Myc function in cells; it is not a c-Myc pathway inhibitor.
• It is unsuitable for therapeutic applications or diagnostic use (APExBIO).
• Long-term storage of peptide solutions is not recommended; stability is best maintained in desiccated powder at -20°C.
• Insolubility in ethanol limits protocol flexibility for some workflows; use DMSO or water (with ultrasound) for dissolution.
• Overuse may saturate antibody binding sites, leading to false negatives in displacement assays.

Compared to 3xflag.com, which discusses strategic insights and translational implications, this review focuses on the peptide’s validated laboratory uses and boundaries.

Workflow Integration & Parameters

• Preparation: Dissolve peptide at ≥60.17 mg/mL in DMSO or ≥15.7 mg/mL in water with ultrasound.
• Storage: Store lyophilized peptide at -20°C, desiccated. Avoid repeated freeze-thaw cycles.
• Antibody Displacement: Add peptide at 1–10 μg/mL to immunoprecipitation or Western blot buffers for competitive inhibition of anti-c-Myc antibody binding (Flagpeptide.com).
• Stability: Use freshly prepared solutions; do not store diluted solutions beyond 24 hours at 4°C.
• Shipping: Product is shipped on blue ice for stability (small molecule standard, APExBIO).

This article clarifies the stability and handling recommendations previously summarized in 3x-flag-peptide.com, with updated solubility and storage guidance.

Conclusion & Outlook

The c-Myc tag Peptide (A6003) from APExBIO is a rigorously benchmarked, high-purity reagent for the displacement of c-Myc-tagged fusion proteins in immunoassays, supporting studies on transcription factor regulation, cell proliferation, and apoptosis. Its defined solubility, storage, and specificity parameters ensure reproducible, high-fidelity results. The peptide is not suitable for therapeutic or diagnostic use but remains a cornerstone for mechanistic research in cancer and cell biology. Ongoing research in transcription factor stability, such as the interplay between c-Myc regulation and selective autophagy pathways (Wu et al., 2021), will further clarify the broader impact of such synthetic reagents in molecular biology workflows.